Navigation Links
A Protein May Help In Weight Loss Treatment

Researchers claim to have discovered a process by which a small protein acts directly within muscles to increase the body's metabolism to burn fat while simultaneously suppressing appetite. // This discovery could potentially become a promising new weight loss treatment.

The new study by a team led by a Canadian researcher, Dr. Greg Steinberg reveals how a small protein acts directly within muscles to increase the body's metabolism to burn fat while at the same time suppressing appetite. The protein is knows as the ciliary neurotrophic factor (CNTF). The Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research, and the Canadian Diabetes Association are funding the research.

They believe that the protein activates an enzyme, skeletal muscle AMP kinase, which increases the ability of the body to metabolise fat and sugar. This study they hope may lead to new strategies to reduce the risk of metabolic abnormalities associated with excess weight.

Steinberg's research shows how CNTF activates similar pathways to those stimulated by exercise. He said that earlier most obesity research has focused on the regulation of appetite by hormones such as leptin. But it is now found that leptin is ineffective in obesity due to the presence of proteins which inhibit their ability to stimulate fat metabolism, he said. He explained that fortunately, CNTF's effects on fat burning are being maintained.

Dr. Diane Finegood, scientific director of the Canadian Institutes of Health Research Institute of Nutrition, stated, this research is an important step for unravelling the complex biological systems controlling body weight, including mechanisms regulating blood sugar levels, food intake, and satiety meaning the feeling of fullness which are crucial to tackling the worldwide epidemic of obesity.

Researchers are working on the pill. But health experts feel it's still a long shot. Actually though Dr.Steinberg is not the first to come to this conclusion, an American pharmaceutical company Regeneron already owns the rights to recombinant CNTF and had completed phase 3 clinical trials of its CNTF medication Axokine. But the trails were discontinued when patients developed antibodies to CNTF that neutralized the effect of the drug.


'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, ... conference “ Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue ... ET. This conference discusses strategies to prevent readmissions in light of the most ...
(Date:3/29/2017)... ... 29, 2017 , ... During the last week of March, Chad Kawa, MD ... individuals in the local community. , Colon cancer is the second leading cause ... cancer while it is small, confined and easier to treat. If you are 50 ...
(Date:3/29/2017)... San Diego, CA (PRWEB) , ... March 29, 2017 , ... ... meningiomas(1,2), and up to 300,000 people each year develop other types of metastatic brain ... spread quickly throughout the brain(3). As efforts focus on finding more effective treatment options, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based ... Pet Protect Law that assists dog owners in creating legally-enforceable pet trusts for ... taking the natural next step to protect their new companion. Says Evan Dunbar, CEO ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL ... that Mercy Medical Center will serve as the official title sponsor of the Baltimore ... June 25, 2017, thousands of women will walk or run the course around the ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... March 30, 2017  Lannett Company, Inc. (NYSE: ... made a $25 million payment against its existing revolving ... combined with the $75 million payment we made earlier ... million in annualized cash interest expense, at current rates" ... Lannett.  "Our business is solid and we continue to ...
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose ... Geography Respiratory Inhalers - our new study reveals trends, ... market heading? If you are involved in this sector you must ... the potential revenues streams to 2027, assessing data, trends, opportunities and ... ...
(Date:3/30/2017)... 30, 2017  Purcell Julie & Lefkowitz LLP, a class ... a potential breach of fiduciary duty claim involving the board ... ). If you are a shareholder of ... this investigation, free of charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
Breaking Medicine Technology: